[Publicly Listed Company Propanc Biopharma Announces Plan to Acquire $100 Million in Ethereum] According to Golden Finance, biopharmaceutical company Propanc Biopharma (NASDAQ: PPCB) announced today (September 2) its plan to acquire $100 million worth of Ethereum within the next 12 months. The company stated that this move will strengthen its corporate strategy in multiple areas, including cryptocurrency investment, drug development, and asset acquisition.